Serious Risks & Warnings Not FDA-approved: Melanotan II is not an approved medication
It is in the phase II trial, and the results of this were recently published in the New England Journal of Medicine
Quick Reference: Standard Protocol Community-documented protocol: 250 mcg subcutaneous in the morning, 3 days per week, for 8-week cycles -- far below the 2.4 mg weekly clinical trial dose, reflecting conservative research-peptide practice
To understand GLP-1 medications for medical weight loss, it helps to understand how these medications work
Explore the full spectrum of benefits and considerations surrounding vitamin B-12 injections in our detailed analysis of B12 Shots & B12 Injections: The Good, Bad and Alternative
The rate of loss increases compared to the first month because you are now at a pharmacologically active dose